Combining AMPs with alkylating agents can also improve the efficacy of cancer therapy by enhancing DNA damage, modulating the tumor microenvironment, overcoming drug resistance, and activating signaling pathways that lead to apoptosis. Here, ADSL is linked to neoplasm.